The dividends account for 20 percent of the company’s net profit, which can be distributed to the owners of the parent entity in the book year 2018 at Rp415.89 billion.
“Compared to last year, the dividend this year declined. Last year, the dividend represented 30 percent (of net profit) and now it declined to 20 percent due to business expansion,” he said.
Kimia Farma expanded the regional business to the Middle East in 2018 so the company needs intensive investment.
“Therefore, we call on our shareholders to see that the 20 percent of dividends we will distribute are aimed at strengthening the fundamental of our entities,” he said.
Kimia Farma posted total assets of Rp9.46 trillion last year, up 55.2 percent from Rp6.10 trillion a year ago.
The business expansion, acceleration and transformation enabled the company to post a net profit of Rp401.79 billion, increasing 21.13 percent from Rp331.7 billion.
The meeting also agreed on a reshuffle of the company’s lineup by discharging Muhammad Umar Fauzi, Pujianto and Arief Pramuhanto.
The company later welcomed Subandi as commissioner, Andi Prazos as business development director and Dharma Syahputra as General Affairs & Human Capital director.